Brief: Edgewise Therapeutics Q4 Basic EPS USD -0.47
22/02/2024 13:00
Feb 22 (Reuters) - Edgewise Therapeutics Q4 net income USD -30.143 million. * Q4 operating expenses USD 33.862 million * Q4 operating income USD -33.862 million
Recent news on Edgewise Therapeutics
See all newsBrief: Edgewise Therapeutics Doses First Patient In Phase 2 Equinox-Hfpef Trial Of Edg-15400
Edgewise Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Edgewise Therapeutics Q2 net loss widens on higher expenses
Brief: Edgewise Therapeutics Q2 Operating Income USD -61.943 Million
U.S. STOCKS ON THE MOVE-RBB Bancorp, Roblox, Open Lending